Imaging Endpoints Establishes Operations in Shanghai


Imaging Endpoints has announced that it has established a new office in Shanghai, China, home to rapidly growing pharmaceutical and biotech innovations in Asia. Imaging Endpoints has expanded its globality to include eight offices across six countries and three continents.

Imaging Endpoints works with nearly all imaging sites globally that participate in clinical trials, and the expansion of operations into Shanghai will enable key team members, such as project managers and radiology experts, to work real-time with their counterparts in China and throughout the Pacific Rim.

More on Imaging Endpoints Shanghai Operations

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.